DB19292InvestigationalVaccines
vCP2292 is under investigation in clinical trial NCT01982487 (Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission).
- Also known as
- ALVAC (2)-NY-ESO-1(M)-TRICOM · ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
- Code names
- vCP2292
What you can answer from here — as of April 23, 2025
Which companies are running trials of vCP2292, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account